Medtronic PLC (NYSE:MDT) Declares Quarterly Dividend of $0.71

Medtronic PLC (NYSE:MDT) announced a quarterly dividend on Thursday, December 4th. Investors of record on Friday, December 26th will be paid a dividend of 0.71 per share by the medical technology company on Friday, January 16th. This represents a c) dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th.

Medtronic has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 49 consecutive years. Medtronic has a payout ratio of 47.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Medtronic to earn $5.83 per share next year, which means the company should continue to be able to cover its $2.84 annual dividend with an expected future payout ratio of 48.7%.

Medtronic Price Performance

MDT stock opened at $101.93 on Friday. Medtronic has a twelve month low of $79.29 and a twelve month high of $106.33. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $130.68 billion, a P/E ratio of 27.47, a PEG ratio of 2.69 and a beta of 0.71. The business has a 50 day simple moving average of $96.65 and a 200-day simple moving average of $92.08.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The company had revenue of $8.96 billion for the quarter, compared to analyst estimates of $8.86 billion. Medtronic’s quarterly revenue was up 6.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.26 earnings per share. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, equities analysts anticipate that Medtronic will post 5.46 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Innova Wealth Partners acquired a new stake in Medtronic during the 3rd quarter valued at $210,000. Tevis Investment Management grew its stake in shares of Medtronic by 1.8% during the third quarter. Tevis Investment Management now owns 53,510 shares of the medical technology company’s stock valued at $5,134,000 after acquiring an additional 958 shares in the last quarter. Groupama Asset Managment increased its position in shares of Medtronic by 62.9% during the third quarter. Groupama Asset Managment now owns 57,642 shares of the medical technology company’s stock worth $5,490,000 after acquiring an additional 22,255 shares during the last quarter. Investment Research Partners LLC acquired a new position in shares of Medtronic in the 3rd quarter valued at approximately $567,000. Finally, ARQ Wealth Advisors LLC acquired a new stake in Medtronic in the third quarter valued at $469,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.